R&D Roundup: Novartis pipeline, CRISPR funding and Opdivo disappointmentsNovartis has showcased its pipeline at its annual meet-the-management day, where investors and analysts got to hear company Share XR&D Roundup: Novartis pipeline, CRISPR funding and Opdivo disappointmentshttps://pharmaphorum.com/views-and-analysis/rd-roundup-novartis-crispr-opdivo/